Study Finds All Major Pharmaceutical Companies Implicated in Bribery Schemes
A study published in February 2026 in the Journal of Law, Medicine & Ethics is the first to compile decades of Organization for Economic Cooperation and Development (OECD) enforcement records into a single analysis. Researchers Kohler, Khan, and Bowra reviewed OECD Working Group on Bribery reports from 1999 through early 2025 and found that virtually […]
Australia Adds New Mental Health Risks to Ozempic and Other Rapid Weight Loss Drugs
The government of Australia has added two new safety warnings about mental health and contraception for the popular GLP-1 agonist drugs like Ozempic designed to facilitate rapid weight loss. The Therapeutic Goods Administration (TGA), which regulates pharmaceutical products for Australia, issued the new safety warnings in December.1 Health professionals say that, while there is no […]
Pfizer Ends Development of Weight-Loss Pill After Liver Injury in Trial Participant
Pfizer, Inc. announced that it is discontinuing development of its experimental daily weight loss pill after a trial participant suffered a liver injury potentially linked to the drug. The company confirmed that the oral GLP-1 drug, danuglipron (PF-06882961), is no longer in development following the incident.1 Pfizer has been studying danuglipron since 2022.2 A Pfizer […]
Nurse’s Death in U.K. Linked to Weight Loss Drug Mounjaro
A 58-year-old nurse’s death has been linked to the popular weight loss drug tirzepatide, sold under the brand name Mounjaro. While her certificate of death lists “multiple organ failure, septic shock, and pancreatitis” as the immediate cause of her passing, “the use of prescribed tirzepatide” is listed as a contributing factor. Susan McGowan had only […]
More Serious Side Effects from Ozempic and Wegovy Weight Loss Drugs
Another woman is suing Ozempic and Wegovy drugmaker Novo Nordisk, claiming that their popular GLP-1 (semaglutide) weight loss drugs led to a near-fatal emergency surgery and a lifelong ileostomy bag attached to her abdomen. Juanita Gantt was prescribed Ozempic and Wegovy by her doctor due to her increased diabetes risk, as she weighed 242 pounds […]
Weight Loss Drugs Ozempic and Wegovy Linked to Vision Loss
Semaglutide, the active ingredient in popular weight loss drugs sold under brand names like Ozempic and Wegovy, has been linked to a condition that causes vision loss, according to a new study published on July 3, 2024 in JAMA Ophthalmology. In the study, patients who were prescribed semaglutide were more likely to develop non-arteritic anterior […]